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Background: Since several neuroprotectives failed to reproduce promising preclinical results under clinical
conditions, efforts emerged to implement clinically relevant endpoints in animal stroke studies. Thereby, insufficient
attention was given on autonomic reactions due to experimental stroke, although clinical trials reported on high
functional and prognostic impact. This study focused on autonomic consequences and body weight changes in a
translational relevant stroke model and investigated interrelations to different outcome measurements.
Methods: Forty-eight rats underwent thromboembolic middle cerebral artery occlusion (MCAO) while recording
heart rate (HR) and mean arterial pressure (MAP). After assessing early functional impairment (Menzies score),
animals were assigned to control procedure or potentially neuroprotective treatment with normobaric (NBO) or
hyperbaric oxygen (HBO). Four or 24 hours after ischemia onset, functional impairment was re-assessed and FITC-
albumin administered intravenously obtaining leakage-related blood–brain barrier (BBB) impairment. Body weight
was documented prior to MCAO and 4 or 24 hours after ischemia onset.
Results: During MCAO, HR was found to increase significantly while MAP decreased. The amount of changes in HR
was positively correlated with early functional impairment (P = 0.001): Severely affected animals provided an increase
of 15.2 compared to 0.8 beats/minute in rats with low impairment (P = 0.048). Regarding body weight, a decrease of
9.4% within 24 hours after MCAO occurred, but treatment-specific alterations showed no significant correlations
with respective functional or BBB impairment.
Conclusions: Future studies should routinely include autonomic parameters to allow inter-group comparisons and
better understanding of autonomic reactions due to experimental stroke. Prospectively, autonomic consequences
might represent a useful outcome parameter enhancing the methodological spectrum of preclinical stroke studies.
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Stroke is an ongoing health issue with high socioeconomic
relevance [1], contributing to 10-12% of deaths in Western
countries [2] and accounting for approximately 4% of
health-care costs [3]. In focal cerebral ischemia, only tissue
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reproduction in any medium, provided the orbeneficial effects in pharmacological clinical trials (e.g., [4]).
On the contrary, numerous potentially neuroprotective
drugs have failed to reproduce their impressive preclinical
results in randomized clinical trials [5-7], e.g., NXY-059 [8].
This situation might be caused by the complex pathophysi-
ology of acute focal cerebral ischemia with deleterious and
beneficial processes occurring simultaneously [5,9], imped-
ing the identification of an exclusively beneficial acting
drug. Exploring these complex mechanisms, preclinical
studies focused on several ischemia-related key featuresl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cular unit [11,12] and diverse aspects of the inflammatory
response [9,13,14] – potentially influencing the long-term
outcome.
Only little attention was given to autonomic conse-
quences in experimental stroke studies as for example
changes in heart rate, arterial blood pressure and
temperature. Conversely, Dirnagl [15] and Fisher et al.
[6] recommended measurement and control of such
parameters throughout preclinical studies, thus enabling
comparative analyses of different interventional groups.
On the other hand, an alteration of sympathetic/parasym-
pathetic functions in terms of an autonomic imbalance due
to acute focal cerebral ischemia, influencing the cardiovas-
cular system and thus the clinical outcome, has been sug-
gested by several clinical studies [16-20]. Particularly, the
insula of the right hemisphere was found to affect the auto-
nomic balance in human stroke, as shown by a decreased
heart rate variability [16,18,20] and increased rate of car-
diac arrhythmias [21-24]. Emphasizing the causal link be-
tween arrhythmias and cerebral ischemia, Pasquini et al.
[25] eletrocardiographically investigated stroke patients
at hospital admission and demonstrated that arrhythmias
are more likely a consequence of insular infarctions in-
stead of their underlying cause. Taking these data into
account, an improved understanding of ischemia-related
alterations of the autonomic system might contribute to
an enhanced preclinical stroke research, predominantly
addressing pathophysiological issues.
Beyond this perspective, autonomic parameters might
also play a role as additional outcome variables in preclin-
ical studies in accordance with the current efforts of using
multiple endpoints in order to substantially enhance the
study quality [6]. The issue of an extended outcome per-
spective becomes increasingly important since clinical
stroke trials mainly used functional parameters as primary
endpoints, in contrast to infarct volume being the central –
and in parts exclusive – focus of attention in most preclin-
ical studies [5,6,26]. As a consequence, recent preclinical
stroke studies more commonly applied functional tests in
order to assess plain neurological deficits (e.g., by Menzies
score [27]), or complex behavioral aspects (e.g., by corner
test [28]). Strengths and weaknesses of available measure-
ments were extensively discussed in several reviews [29-
35]. Searching for further applicable endpoints in preclin-
ical research, the change in body weight as surrogate for
general health might play an important role, because this
parameter is already in use for detecting critical health con-
ditions [36]. Furthermore, first attempts were made to cor-
relate body weight changes with the routinely used
infarct volume [37,38] and functional impairment [38].
Concerning further translational issues in stroke re-
search, the underlying rodent models of focal cerebral
ischemia have often been discussed critically: Mostprevious studies applied techniques with artificial vessel
occlusion by electrocautherization or filament insertion,
while thromboembolic animal models largely mimic
human pathophysiology [26,39,40].
The present study investigated autonomic reactions –
in particular changes of heart rate and mean arterial
pressure – during right-sided thromboembolic focal
cerebral ischemia in rats to explore their natural course
and the interrelations with early functional impairment,
assessing the significance as potential outcome para-
meters. Moreover, body weight changes – also represent-
ing a promising surrogate for general health following
focal cerebral ischemia – were addressed in animals
undergoing a potentially neuroprotective treatment with
normobaric (NBO) and hyperbaric oxygen (HBO). These
interventions were chosen since our previous work [41]
has demonstrated differentiated effects on functional im-
pairment and blood–brain barrier (BBB) damage.
Methods
Study design and content
Data from 48 male Wistar rats weighing 307 ± 35 g – taken
from our previous work [41] – were retrospectively investi-
gated. The underlying study had been conducted according
to the European Communities Council Directive (86/609/
EEC) and was approved by local authorities (Regierungsprä-
sidium, Leipzig, Germany). All animals were delivered by
Charles River (Sulzfeld, Germany) and subjected to right-
sided focal cerebral ischemia by middle cerebral artery oc-
clusion (MCAO) using a thromboembolic model originally
described by Zhang et al. [42], and modified as previously
characterized [43]. Thereby, a polyethylene (PE) tubing with
tapered end was advanced via the external carotid artery
into the internal carotid artery (ICA) until the origin of the
middle cerebral artery. In this position, a weight-adapted
blood clot with a mean length of 45 ± 3 mm was injected.
Finally, the catheter was removed to restore blood blow in
the ICA. During surgery, anesthesia was arranged by using
isoflurane (70% N2O / 30% O2), and temperature mainten-
ance (target temperature 37°C) was ensured with a thermo-
statically controlled heating pad (Fine Science Tools,
Heidelberg, Germany) including a rectal probe. As the first
step of the surgical procedure, PE tubes were inserted into
the femoral artery for measurement of heart rate and mean
arterial pressure, and the femoral vein for future substance
application.
After MCAO induction and recovery from anesthesia,
animals were assigned to control procedure, or treatment
with NBO or HBO (n = 16 each). NBO and HBO were
started 2 hours after ischemia onset and were performed
in a pure oxygen-filled hyperbaric chamber (Sayers/
Hebold, Cuxhaven, Germany). NBO was conducted
under normal ambient pressure (1.0 absolute atmo-
spheres) and HBO at 2.4 absolute atmospheres, each for
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24 hours (n = 8 per treatment group) after ischemia onset,
Fluorescein isothiocyanate (FITC)-albumin with a dosage
of 20 mg/1 mL saline (Sigma, Taufkirchen, Germany) was
administered intravenously for the characterization of
BBB impairment. Following a circulation time of usually
1 hour, the animals were sacrificed in deep narcosis. After
transcardial perfusion with saline and 4% paraformalde-
hyde (PFA) in 0.1 M phosphate-buffered saline, pH 7.4
(PBS), the brains were removed from the skull and
immersed in PFA overnight, followed by the equilibration
in 30% phosphate-buffered sucrose. The complete study
setup including procedures and endpoints is summarized
in Figure 1A.
Study endpoints
Heart rate and mean arterial blood pressure were
assessed during MCAO-related surgery by using a com-
mercial monitoring system (Datex, Helsinki, Finland)
connected with the PE tube inserted in the femoral ar-
tery. Values were obtained continuously while the follow-
ing 3 time points were recorded for further calculations:
directly after catheter placement (onset of surgery),
shortly after MCAO induction (clot injection) and shortly
before the surgical procedure was completed (end of
surgery).
Body weight was measured with a scale (Mettler
Toledo BBA425-3SM, Gießen, Germany) prior to surgery
(baseline), as well as 4 and/or 24 hours after ischemia
induction.
Functional impairment was assessed after recovery
from surgery-related anesthesia (early functional impair-
ment, M0), as well as 4 hours (M4h) and/or 24 hours
(M24h) after ischemia induction by using the Menzies
score [27], which is scaled from 0 “no apparent deficits”
up to 4 “spontaneous contralateral circling”.
BBB impairment was characterized by using FITC-
albumin as permeability marker, as previously described
in detail [44]. Briefly, serial brain sections of 30 μm
thickness were cut coronally using a freezing microtome
and stored in 0.1 mol/L Tris-buffered saline, pH 7.4
(TBS) containing sodium azide. To identify sections with
clearest infarct presentation as indicated by FITC-
albumin leakage, a first screening was performed with a
conventional fluorescence microscope (Axioplan, Zeiss,
Jena, Germany). For this purpose, sections were exten-
sively washed with TBS, briefly rinsed with distilled water,
mounted on fluorescence-free slides, air-dried and cover-
slipped with Entellan in toluene (Merck, Darmstadt, Ger-
many). Afterwards, the neighboring serial sections were
washed with TBS, blocked with TBS containing 2% bovine
serum albumin and 0.3% Triton X-100 (TBS-BSA-T) for
1 hour. Subsequently, the green fluorescent signal was
enhanced by incubation with carbocyanine (Cy)2-anti-FITC IgG (20 μg/mL TBS-BSA-T; Jackson ImmunoRe-
search, West Grove, PA) for 1 hour. The sections then
were washed, mounted and coverslipped as described
above. The ratio of fluorescence-based paravasal and
intravasal intensity of enhanced FITC-albumin served as
surrogate for BBB impairment, analyzed by a fluores-
cence microscope (Axioplan 2, Zeiss) including struc-
tured-light confocal system (OptiGrid, Qioptiq, Fairport,
NY), digital camera (ORCA-ER, Hamamatsu, Hama-
matsu City, Japan) and imaging software (Volocity 4.3,
PerkinElmer, Waltham, MA). In detail, routinely 3 ves-
sels with clearest FITC-albumin leakage in the lesion-
bordering zone were selected in each animal. For each
of these vessels, measurements were done with 3 cylin-
drical regions of interest (ROIs; diameter 2 μm, 9 con-
focal layers, z-interval 0.5 μm) that were positioned in
the paravasal space with a distance of approximately
2 μm from the vessel wall, and 3 ROIs that were posi-
tioned directly in the vessel (Figure 1B-E). Finally, the
assessed mean intensities within the ROIs (setup: 40x
magnification, further digital zoom if required, water
immersion objective with numerical aperture 1.4, expos-
ure time 80 ms, gain 0, offset 0, super grid quality, grid
gain 3x, excitation Cy2 480 nm, emission 527 nm, exci-
tation Cy3 545 nm, emission 610 nm) were used to cal-
culate means which served as source for the extra-/
intravasal ratio.
Statistical analysis
Calculations were made with SPSS (Version 18.0, SPSS
Inc., IBM Company, Chicago, IL). Wilcoxon test, Mann–
Whitney U test and one-way analysis of variance
(ANOVA) were performed for intra- and inter-group dif-
ferences. Pearson correlations and partial correlations
were used for testing interrelations. Overall, a P< 0.05
was considered as statistically significant. Data are given
as mean ± standard deviation, unless otherwise indicated.
Results
The surgical procedure for inducing right-sided thrombo-
embolic stroke was performed with a mean duration of
69 ± 22 minutes. In parallel, the body temperature was
kept stable from onset (37.2 ± 0.4°C) to the end of surgery
(37.4 ± 0.3°C), although this marginal increase achieved
statistical significance (Wilcoxon test, P = 0.003).
Obtained changes of heart rate and mean arterial pres-
sure during ischemia induction are shown in Figure 2. In
the overall sample, a significant increase in heart rate of
about 9 ± 21 beats/minute occurred from onset to the end
of surgery (Wilcoxon test, P = 0.006). In contrast, the mean
arterial pressure declined about 3 ± 12 mmHg during sur-
gery with a significant change between onset of surgery
and clot injection (Wilcoxon test, P = 0.039). Interestingly,
the change in heart rate was clearly correlated with early
Figure 1 Study overview (A) with defined time points for assessing heart rate and mean arterial blood pressure, as well as body
weight, functional impairment and blood–brain barrier impairment. Native representative examples (B, C) of blood–brain barrier impairment
located in the rat brain affected by thromboembolic stroke and clearly indicated by leakage of FITC-albumin from the intra- to the extravasal
space at 40x magnification. Further affected vessels (D, E) with exemplarily inserted regions of interest for quantification of BBB impairment. Long-
term stabilization of the green fluorescent signal of FITC-albumin was ensured by an enhancing technique using carbocyanine 2-anti-FITC IgG.
Figures B-D were slightly modified by enhancing the green canal on the tone curve using Corel Photo-Paint (Version 12.0, Corel Corp., Ottawa,
Canada), applying the same setup for all 4 Figures. Scale bars in B-E: 30 μm.
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embolic stroke (M0; Pearson, r = 0.50; P = 0.001) repre-
senting an explained variance of 25%, while the change in
mean arterial pressure did not show a significantcorrelation (Pearson, r = 0.06; P = 0.684). Figure 3 displays
this relationship in a more detailed manner while separat-
ing the early functional impairment into a group with low
deficit (Menzies score <3) and severe deficit (Menzies
Figure 2 Course of heart rate and mean arterial pressure (MAP)
during surgery inducing right-sided thromboembolic stroke.
Bars represent means and added lines indicate standard errors.
Sample sizes (time point: heart rate / MAP): onset of surgery: n = 47 /
n = 47; clot injection: n = 45 / n = 45; end of surgery: n = 44 / n = 44.
*P< 0.05; **P< 0.01.
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jects with severe early functional impairment became even
clearer (Mann–Whitney U test, P = 0.048). Additionally,
the interrelations between changes in heart rate and mean
arterial pressure, as well as their relationship to FITC-albu-
min leakage as surrogate for BBB impairment were ana-
lyzed in the whole sample. A non-significant correlation
was found between changes in heart rate and mean arterial
pressure (Pearson, r = 0.15; P = 0.336). Furthermore, nei-
ther the change of heart rate (Pearson, r = 0.20; P = 0.195)
nor the change of mean arterial pressure (Pearson, r =Figure 3 Intra-surgical changes in heart rate and mean arterial
pressure (MAP) depending on early functional outcome, divided
into a group with low deficit (Menzies score <3) and severe
deficit (Menzies score ≥3). Bars represent means and added lines
indicate standard errors. Sample sizes (group: heart rate / MAP):
Menzies score <3: n = 17 / n = 17; Menzies score ≥3: n = 27 / n = 27.
*P< 0.05.−0.07; P = 0.646) was significantly correlated with BBB
impairment.
In the overall sample, body weight as surrogate for gen-
eral health was found to decrease of about 12 ± 6 g from
baseline to 4 hours (Wilcoxon test, P = 0.000) and about
31 ± 8 g from baseline to 24 hours (Wilcoxon test, P =
0.000), which represents a loss of 4.1% and 9.4%, respect-
ively, from baseline body weight. Due to the finding that
baseline body weight did not differ between the treatment
groups (NBO, HBO) and the control group (ANOVA, F =
2.1; P = 0.129), the obtained changes were analyzed accord-
ing to the 3 interventional groups (Figure 4). Thereby, a
tendency for decreased loss of body weight during the first
24 hours after ischemia onset was found in the HBO group,
although the overall changes were not statistically signifi-
cant (baseline to 4 hours: ANOVA, F = 1.8; P = 0.189; base-
line to 24 hours: ANOVA, F = 2.3; P = 0.130). Figures 5 and
6 summarize the interrelations between changes in body
weight and functional impairment as well as BBB impair-
ment, which were addressed since the time point-corrected
correlation of functional impairment at 4/24 hours and
BBB impairment at 5/25 hours revealed a significant coeffi-
cient (partial correlation, r = 0.37; P = 0.011) in the overall
sample. Unexpectedly, changes in body weight were not
significantly associated with changes in functional impair-
ment or BBB impairment (Figure 5, color-coded in yellow).
To consider potential treatment effects, the coefficients
were separately calculated for each interventional group.
Here, the lack of significant coefficients remained when fo-
cusing on control-proceeded (Figure 5, color-coded in tur-
quoise) and NBO- or HBO-treated (Figure 6) animals
separately. Therefore, treatment-associated changes in func-
tional or BBB impairment were not sufficiently reflected by
simultaneous changes in body weight. The differently
diminished impairment within 24 hours after ischemia
onset was predicted by 18.5% (explained variance) of changeFigure 4 Changes from baseline body weight to 4 and 24 hours
depending on assigned treatment. Bars represent means and
added lines indicate standard errors. Sample sizes (treatment group:
baseline-4 h / baseline-24 h): control: n = 8 / n = 8; NBO: n = 8 / n =
8; HBO: n = 8 / n = 8.
Figure 5 Correlation matrix between changes (Δ) in body weight, functional impairment and blood–brain barrier (BBB) impairment in
the overall sample (color-coded in yellow) and the control group (color-coded in turquoise). Functional impairment was assessed
according to Menzies et al. [27]; BBB impairment was measured as previously described by Michalski et al. [41,44]; sample sizes for calculations in
the overall sample: ranging from n = 23 to n = 38, and for calculations in controls: ranging from n = 8 to n = 11.
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pared to 41.0% in NBO- and 0.6% in HBO-treated ani-
mals. Remarkably, the underlying correlation coefficient
in animals receiving NBO was negative (r = −0.64), in
contrast to controls which were characterized by a posi-
tive coefficient (r = 0.43).
Discussion
The first part of the present study aimed on autonomic
consequences – particularly heart rate and mean arter-
ial blood pressure – during right-sided focal cerebral is-
chemia in rats. A thromboembolic stroke model was
applied with the objective to mimic the human patho-
physiology as best as possible [26,40]. In this regard,
right-hemispheric cerebral ischemia was of special inter-
est since clinical data indicated autonomic reactions pre-
dominantly in ischemic stroke involving the right
hemisphere when compared to the left [16,18,20,22-24].
Although changes in body temperature appear interesting
in this context [37,45,46], this parameter was controlled
during the surgical procedure using a heating pad to avoid
anesthesia-related cooling, which meets the standard of
care in this field [6,15].Figure 6 Correlation matrix between changes (Δ) in body weight, fun
animals which underwent treatment with NBO (normobaric oxygen; c
in turquoise). Functional impairment was assessed according to Menzies e
Michalski et al., [41,44]; sample sizes for calculations in NBO-assigned anima
animals: ranging from n = 7 to n = 16.The first main finding of the present study was a sig-
nificant increase in heart rate and decrease in mean ar-
terial pressure during the induction of right-sided
thromboembolic stroke in rats representing most prob-
ably specific ischemia-related autonomic alterations,
which have – to the authors’ best knowledge – not been
reported previously for this model. These results provide
evidence for such reactions in the applied stroke model,
which appears relevant for translational issues since clin-
ical studies also described autonomic imbalances after
right-hemispheric ischemia, especially involving the in-
sula [16,18,20-24]. Summarizing the few available data
from animal research that have addressed autonomic
changes after focal cerebral ischemia [47], it is remark-
able that probably the used different animal species and
strains, time points of assessing arterial pressure and
heart rate, sides of infarction, and especially the most
commonly used invasive and hence artificial MCAO
model led to inconsistent results. In detail, Butcher et al.
[48] reported a decrease in mean arterial pressure 5 hours
following right-sided MCAO in spontaneously hyperten-
sive rats, which could not be replicated by the authors
when using Wistar-Kyoto rats. The same authors alsoctional impairment and blood–brain barrier (BBB) impairment in
olor-coded in yellow) and HBO (hyperbaric oxygen; color-coded
t al. [27]; BBB impairment was measured as previously described by
ls: ranging from n = 8 to n = 11, and for calculations in HBO-assigned
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MCAO in spontaneously hypertensive rats, but again
this effect was not observed in Wistar-Kyoto rats [48].
On the other hand, Hachinski et al. [49] performed
right-sided MCAO in rats which led to an increased
mean arterial pressure 4 hours after ischemia onset when
compared to controls and left-sided ischemia. In a fur-
ther study by Cechetto et al. [50], mean arterial pressure
did not significantly differ from −30 to 90 and 180 min-
utes following left-sided MCAO only, but a decreasing
course was observed following sham procedure or occlu-
sion of the ipsilateral common carotid artery. With re-
spect to the clinically demonstrated relevance of the
insular cortex [19-21,23], Smith et al. [51] performed
left-sided MCAO in cats and showed that insular in-
volvement results in increased catecholamine plasma
levels when compared to non-insular infarction. Interest-
ingly, the present study revealed a correlation between
the amount of changes in heart rate during right-sided
thromboembolic stroke and early functional outcome
(see Figure 3), indicating a quantitative and not only
qualitative relationship. The derived hypothesis of a link
between the amount of autonomic reactions and size of
affected brain tissue is supported by a recent study from
Purins et al. [52]: While standardizing a brain death
model in pigs, a growing intracranial pressure due to an
increased intracranial volume led to an increase in heart
rate as well as a decrease in mean arterial and cerebral
perfusion pressure – finally disrupting the cerebral blood
flow. Taken together, the first part of our study yields the
suggestion to routinely record autonomic parameters in
future preclinical stroke studies, first, to report on poten-
tial inter-group differences in efficacy-aimed approaches,
and second, to explore interrelations of focal cerebral is-
chemia and autonomic consequences in approaches pri-
marily addressing pathophysiological issues. For the
latter one, visualization tools for cerebral vessel occlu-
sions and related blood flow phenomena (e.g., magnetic
resonance imaging-based angiography and laser Doppler
flowmetry) might be appropriate to establish the causal
link. The presented findings further indicate that auto-
nomic reactions in thromboembolic stroke models might
be useful as additional outcome parameters, prospect-
ively extending the study spectrum methodologically.
The second part of the present study dealt with changes
in body weight, which represents an already used surro-
gate for general health [36]. Therefore, this parameter
might also be a useful outcome measurement in preclin-
ical stroke studies. In the overall sample, a decrease in
body weight of about 4% during the first 4 hours, and
about 9% during the total 24-hour observation period was
found. Comparable results were published by Overgaard
et al. [38], who determined a weight loss between 4.8 and
5.9% within 24 hours after thromboembolic right-sidedMCAO in rats. Additionally, Lubjuhn et al. [53] assessed
body weight changes in mice subjected to distal MCAO
and provided a loss of about 6.6% during the first 24 hours
after ischemia onset. Furthermore, Dittmar et al. [45]
reported markedly higher values of body weight loss (ap-
proximately 15–20%) 2 days following MCAO in rats
when compared to sham-operated animals (about 5%).
However, differing post-surgical changes in body weight
have caused an ongoing discussion on underlying mechan-
isms – amongst others the applied models of ischemia ap-
pear to play an important role in this context [32,37,45,54].
Besides the frequently discussed issue of early MCAO-
induced weight loss, a study by Boyko et al. [55] also fo-
cused on the long-term recovery of body weight and con-
firmed model-related differences also at day 14 and 28
after ischemia onset. To explore whether early body weight
changes − as shown here − are useful to differentiate treat-
ment effects following thromboembolic stroke, the influ-
ence of a potentially neuroprotective treatment with NBO
and HBO has been investigated. This approach became
interesting since the administration of NBO (60 minutes,
starting 2 hours after ischemia onset) led to a signifi-
cantly improved functional impairment during a 24-hour
observation period, while controls showed a progressive
stroke with significantly worsened impairment and no
functional changes were observed in HBO-treated ani-
mals [41]. Concerning a further relevant outcome par-
ameter, in the same study NBO and HBO caused a
tendency to reduce BBB impairment, as indicated by the
extra-/intravasal ratio of FITC-albumin, while this effect
was absent in the control group [41]. Unfortunately, the
present study revealed no significant differences of ische-
mia-related body weight changes between controls,
NBO- and HBO-treated animals. To further explore this
finding, correlations have been calculated between
changes in body weight, functional and BBB impairment
(Figures 5 and 6) – overall resulting in non-significant
interrelations. Taking the obtained tendencies during the
24-hour observation period into account, it is note-
worthy that NBO resulted in a negative coefficient
(r = −0.64), hence the functional improvement in this
group was associated with decreasing body weight loss.
In contrast, an inverse situation was observed in the con-
trol group (r = 0.43), indicating here that functional wor-
sening was associated with increasing weight loss. In
general, the observed lack of significant interrelations be-
tween changes in body weight and 2 further clinically
relevant parameters limits the usefulness of body weight
as sensible outcome parameter. However, this finding
needs to be discussed critically, since previous studies
have demonstrated significant correlation coefficients of
0.9 [37] and 0.59 [38] between weight loss and infarct
volume. These differences might be caused by different
species investigated, time points of assessment and
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[37] vs. rats, 24 hours after thromboembolic MCAO,
partially involving the internal carotid artery [38]. Taken
together, further research is required to identify specific
mechanisms of body weight changes following experi-
mental stroke, and to explore the interactions of these
changes and other outcome parameters. This approach
should preferably include both short- as well as long-
term observations.
The present study has some limitations: The retro-
spective design might have produced bias and, therefore,
the obtained results need to be confirmed in a prospect-
ive setting including an extended catalog of autonomic
parameters (e.g., breathing frequency, heart rate variabil-
ity). The use of potentially neuroprotective oxygen at 2
different ambient pressures allows only conclusions with
respect to these interventions. However, the application
of oxygen at other ambient pressures or the use of alter-
native neuroprotective approaches might have provided
different changes in body weight or substantial interrela-
tions with both functional and BBB impairment.
Conclusions
In summary, this study demonstrated a significant in-
crease in heart rate and decrease in mean arterial pres-
sure during induction of right-sided thromboembolic
stroke in rats, indicating specific autonomic alterations
in this clinically relevant model. Interestingly, the
amount of changes in heart rate was significantly asso-
ciated with early functional outcome and therefore
qualifies as potential outcome parameter in future
stroke studies. Concerning translational issues in stroke
research, these findings become relevant since auto-
nomic consequences of stroke models often remained
unattended in preclinical studies, whereas clinical stud-
ies have shown autonomic imbalances due to right-
hemispheric cerebral ischemia with prognostic impact.
In addition, body weight was found to be decreased due
to thromboembolic cerebral ischemia but cannot be
considered as sensitive outcome parameter in different
oxygen-related treatment approaches.
Further studies are required to investigate autonomic
consequences in rodent stroke models in more detail by
using extended panels of parameters, and with special
emphasis on potentially influencing factors like lesion
side, size, vessel status, resulting blood flow alterations
and different neuroprotective approaches.
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